Physician
Hyder, Tara
Hyder, Tara was paid $561K by Medicaid between Nov 2020 and Dec 2024, across 12 billing codes. Its largest line is G9012, Other specified case management service not elsewhere classified — 51% of everything it billed.
33Billing provider infoHYDER, TARA
BETHEL PARK, PA 15102
BETHEL PARK, PA 15102
33aNPI1932392131assigned 08/21/2007
33bProvider typeInternal Medicine Physician
28Total paid$561K
24GClaims6,710
24DCodes billed12
24AFirst – last monthNov 2020 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Pennsylvania
Rank by total paid#42 of 1,726
Median peer was paid$6K
This provider vs. median86×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 66 | $3K | |
| 2021 | 745 | $52K | |
| 2022 | 1,215 | $122K | |
| 2023 | 1,978 | $160K | |
| 2024incomplete | 2,706 | $224K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G9012 | Other specified case management service not elsewhere classified | 51% | 968 | 968 | $286K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 1,432 | 1,277 | $87K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 11% | 1,103 | 1,053 | $61K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 8.4% | 1,484 | 1,467 | $47K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.1% | 932 | 879 | $40K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.4% | 160 | 159 | $19K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.1% | 143 | 142 | $12K |
| 80305 | <1% | 396 | 342 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 14 | 14 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 35 | 35 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 31 | 31 | $1K |
| 81002 | <1% | 12 | 12 | $37.68 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.